DEXTENZA is a corticosteroid intracanalicular insert placed in the punctum, a natural opening in the eye lid, and into the canaliculus and is designed to deliver dexamethasone to the ocular surface for up to 30 days without preservatives. Following treatment, DEXTENZA resorbs and exits the nasolacrimal system without the need for removal.
Eye News TV provides eye care education for both doctors and patients. Content creator, Tom Pace, interviews doctors and patients about technology, experience and patient outcomes.
Other channels include Dry Eye News TV, Retina News TV, Glaucoma News TV, Cataract News TV.
